Țară: Japonia
Limbă: engleză
Sursă: すりの適正使用協議会 RAD-AR Council, Japan
Gilteritinib fumarate
Astellas Pharama Inc.
Gilteritinib fumarate
pale yellow tablet, diameter: approx. 7.1 mm, thickness: approx. 3.5 mm
Print on wrapping: ゾスパタ40mg, house-mark, house-mark+235, アステラス製薬, XOSPATA 40mg
Drug Information Sheet("Kusuri-no-Shiori") Internal Revised: 08/2022 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: XOSPATA TABLETS 40MG ACTIVE INGREDIENT: Gilteritinib fumarate DOSAGE FORM: pale yellow tablet, diameter: approx. 7.1 mm, thickness: approx. 3.5 mm IMPRINT OR PRINT ON WRAPPING: ゾスパタ 40mg, house-mark, house-mark+235, アステラス製薬, XOSPATA 40mg EFFECTS OF THIS MEDICINE This medicine suppresses growth of tumor cells by inhibiting FMS-like tyrosine kinase 3 (FLT3). It is usually used for the treatment of patients with relapsed or refractory FLT3 mutation- positive acute myeloid leukemia. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines or foods. If you have a risk of prolonged QT interval or a history of it. ・If you are pregnant or breastfeeding. ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE) ・ Your dosing schedule prescribed by your doctor is(( to be written by a healthcare professional )) ・In general, for adults, take 3 tablets (120 mg of gilteritinib) at a time, once a day. The dosage may be adjusted according to the condition, but it should not exceed 5 tablets (200 mg) at a time, once a day. Strictly follow the instructions. ・Examinations including FLT3 mutation test (using bone marrow or peripher Citiți documentul complet